Hirohito Naito

9PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 18, 2026
Association Between Early Perioperative Fentanyl Exposure and Dose-Normalized Tacrolimus Exposure After Kidney Transplantation.

|Aug 28, 2026
Darolutamide-based triplet therapy versus androgen receptor pathway inhibitor-based doublet therapy for metastatic castration-sensitive prostate cancer: a real-world analysis using the TriNetX database.

|Jan 31, 2026
Efficacy of Photodynamic Diagnosis Is Confined to the Low-Risk Subgroup of Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched Analysis.

Yohei Abe, Rikiya Taoka, Asuka Kaji

|Dec 26, 2025
Real-world efficacy of switching androgen receptor signaling inhibitor therapy following apalutamide discontinuation because of adverse events in advanced prostate cancer: a multicenter study.

Yoichiro Tohi, Takuma Kato, Kengo Fujiwara

|Feb 05, 2025
Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy.

Shuhei Hara, Wataru Fukuokaya, Jun Miki

|Sep 18, 2024
Development and validation of a model to predict the outcomes of radical cystectomy in patients with bladder cancer.

Wataru Fukuokaya, Jun Miki, Rikiya Taoka

Pageof 2

Frequent Collaborators

6 joint publications

Yoichiro Tohi

6 joint publications

Mikio Sugimoto

5 joint publications

Rikiya Taoka

4 joint publications

Takuma Kato